 "Weekly stock recommendations by Religare Broking: Buy Sun Pharma, TVS Motor")
Sun Pharmaceutical Industries Limited
Recommendation: Buy
Last Close: 506.15
Initiation range: 500-505
Target: 540
Stop loss:485
Also Read
Sun Pharma has been witnessing profit taking for the last two months, after a strong rally from roughly 310 to 560+ levels. It has reached the support zone of major moving averages on multiple time frames and they all coincide closer to 485 levels. Indications are in the favor of gradual recovery from hereon thus we advise creating fresh longs in the given range.
Sumitomo Chemical India Limited
Recommendation: Buy
Last Close: 297.75
Initiation range: 292-296
Target: 320
Stop loss: 280
Sumichem has taken a pause after a breakout from a consolidation zone and currently hovering in a narrow range. The chart pattern combined with the positioning of the indicators is pointing towards a strong rise in the near future. Traders shouldn’t miss this opportunity to accumulate in the mentioned zone.
TVS Motor Company Limited
Recommendation: Buy
Last Close: 470.25
Initiation range: 464-468
Target: 494
Stop loss: 452
The auto pack has been showing tremendous resilience on every dip and TVS Motor is keeping with the trend. It has rebounded sharply after a dip last week and again trading closer to the high of the calendar year. We expect the prevailing momentum to continue.
Oil & Natural Gas Corporation Limited
Recommendation: Sell October Futures
Last Close: 69.80
Initiation range: 70-72
Target: 60
Stop loss: 76
ONGC has been underperforming the index for the last several years as it’s trading in a prolonged downtrend. In line with the others, it also witnessed a rebound from the March lows but failed to sustain above the resistance barrier of 100 EMA on the daily chart despite multiple attempts.The recent bounce to the short-term moving average has resulted in the formation of a fresh shorting pivot on the daily chart.
===================================
Note: All stock prices are in Rs.
Disclaimer: Ajit Mishra is VP - Research at Religare Broking.
http://www.religareonline.com/disclaimer
===================================
Note: All stock prices are in Rs.
Disclaimer: Ajit Mishra is VP - Research at Religare Broking.
http://www.religareonline.com/disclaimer
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%